Moreover, according to CIDER the AP-1complex, together with the IRF1 TF, promotes the expression of RARA, linking theErbB pathway activation to the suppression of estrogen receptor activity, shown inthe more aggressive phenotypes of breast cancer. Here, IRF1 is linked to breast carcinoma.